Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis

被引：21
|
作者：
Hajivalili, Mahsa [1 ,2 ]
Pourgholi, Fatemeh [1 ,2 ]
Kafil, Hossein Samadi [3 ]
Jadidi-Niaragh, Farhad [1 ,2 ,4 ]
Yousefi, Mehdi [1 ,2 ,3 ]
机构：
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Med, Dept Immunol, Tabriz, Iran
[3] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[4] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran
来源：
CURRENT STEM CELL RESEARCH & THERAPY | 2016年 / 11卷 / 01期
关键词：
Amyotrophic lateral sclerosis; mesenchymal stem cells; stem cell; treatment; MARROW STROMAL CELLS; HUMAN ADIPOSE-TISSUE; RAT MODEL; DISEASE PROGRESSION; GROWTH-FACTORS; MOUSE MODEL; TRANSPLANTATION; ALS; BRAIN; DELIVERY;
D O I：
10.2174/1574888X10666150902095031
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by motor neuron (MN) dysfunction, progressive paralysis, and death. Although several therapeutic approaches have been used for treatment of ALS, little success has been achieved. Natural vectors such as mesenchymal stem cells (MSCs) can be a promising tool for overcoming therapeutic problems. MSCs have multipotential characteristics such as the ability to differentiate into variety of cell types, easy access, immunomodulation, tissue repair, exertion of trophic factors, exosome secretion and efficient homing. In this review, we will discuss the characteristics of MSCs and their possible therapeutic mechanisms in ALS patients.
引用
收藏
页码：41 / 50
页数：10
相关论文
共 50 条
  • [41] Hematopoietic stem cells fail to allieviate amyotrophic lateral sclerosis
    Kerstetter, Amber E.
    Miller, Robert H.
    REGENERATIVE MEDICINE, 2009, 4 (01) : 33 - 34
  • [42] Neural Stem Cells as a Therapeutic Approach for Amyotrophic Lateral Sclerosis
    Ferraiuolo, Laura
    Frakes, Ashley
    Kaspar, Brian K.
    MOLECULAR THERAPY, 2013, 21 (03) : 503 - 505
  • [43] Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
    Du, Hongmei
    Huo, Zijun
    Chen, Yanchun
    Zhao, Zhenhan
    Meng, Fandi
    Wang, Xuemei
    Liu, Shiyue
    Zhang, Haoyun
    Zhou, Fenghua
    Liu, Jinmeng
    Zhang, Lingyun
    Zhou, Shuanhu
    Guan, Yingjun
    Wang, Xin
    CELLS, 2023, 12 (06)
  • [44] Treatment of Amyotrophic Lateral Sclerosis
    Andrew Eisen
    Markus Weber
    Drugs & Aging, 1999, 14 : 173 - 196
  • [45] TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
    DORMAN, JD
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 209 (01): : 112 - &
  • [46] TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1955, 1 (JAN8): : 118 - 118
  • [47] Treatment of amyotrophic lateral sclerosis
    Eisen, A
    Weber, M
    DRUGS & AGING, 1999, 14 (03) : 173 - 196
  • [48] SYSTEMIC TREATMENT WITH ADIPOSE-DERIVED MESENCHYMAL STEM CELLS AMELIORATES CLINICAL AND PATHOLOGICAL FEATURES IN THE AMYOTROPHIC LATERAL SCLEROSIS MURINE MODEL
    Marconi, S.
    Bonaconsa, M.
    Scambi, I.
    Squintani, G. M.
    Rui, W.
    Turano, E.
    Ungaro, D.
    D'Agostino, S.
    Barbieri, F.
    Angiari, S.
    Farinazzo, A.
    Constantin, G.
    Del Carro, U.
    Bonetti, B.
    Mariotti, R.
    NEUROSCIENCE, 2013, 248 : 333 - 343
  • [49] Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis
    Karussis, D.
    Karageorgiou, C.
    Gowda-Kurkalli, B.
    Kassis, I.
    Vaknin-Dembinsky, A.
    Gomori, J. M.
    Bulte, J.
    Petrou, P.
    Ben-Hur, T.
    Slavin, S.
    HUMAN GENE THERAPY, 2010, 21 (05) : 650 - 650
  • [50] Pilot Phase I/II Clinical Trial with Autologous Mesenchymal Stem Cells in Patients with Multiple Sclerosis and Amyotrophic Lateral Sclerosis
    Karussis, Dimitrias
    Karageorgiou, Clementine
    Gowda-Kurkalli, Basan
    Vaknin-Dembinsky, Adi
    Gomori, John Moshe
    Kassis, Ibrahim
    Petrou, Panayiota
    Bulte, Jeff
    Slavin, Shimon
    NEUROLOGY, 2010, 74 (09) : A295 - A295
12345